Deep learning in next-generation vaccine development for infectious diseases.

Documenti analoghi

• Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development.
  di: Chakraborty, Chiranjib, et al.
  Pubblicazione: (2025)
• Regulation of miRNA in Cytokine Storm (CS) of COVID‐19 and Other Viral Infection: An Exhaustive Review
  di: Chiranjib Chakraborty, et al.
  Pubblicazione: (2025)
• Understanding the landscape of cross-species transmission, epidemiology, phylogenetics, and antigenicity of HPAI strain A(H5N1) causing a recent outbreak in the USA.
  di: Chakraborty, Chiranjib, et al.
  Pubblicazione: (2025)
• Quercetin, Isoquercitrin, and Quercetin‐3‐Rutinoside: Understanding the Pharmacological, Organoleptic, ADME Properties, Human Health Toxicity, Ecological Risk, and Cosmetic Risk of Using Integrative Bioinformatics
  di: Anirban Debnath, et al.
  Pubblicazione: (2025)
• Autoantibodies in COVID‐19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives
  di: Srijan Chatterjee, et al.
  Pubblicazione: (2024)